To compare quantitative background parenchymal enhancement (BPE) measurements in women categorized as having high versus non-high lifetime breast cancer risk, and to analyze differences between BRCA mutation carriers and noncarriers.
Key Findings:
Quantitative BPE measurements differ significantly between high-risk and non-high-risk women, indicating potential for improved risk assessment.
BRCA mutation carriers exhibited different BPE characteristics compared to noncarriers, suggesting a need for tailored screening approaches.
Clinical factors from classical risk models correlate with quantitative BPE measurements, reinforcing the relevance of these models.
Interpretation:
The study suggests that quantitative BPE may serve as a valuable biomarker for assessing breast cancer risk, potentially enhancing the accuracy of existing risk models.
Limitations:
The study's retrospective nature may introduce selection bias, potentially affecting the generalizability of the findings.
Exclusion criteria may limit the applicability of results to broader populations, necessitating caution in interpretation.
Conclusion:
Quantitative assessment of BPE could significantly enhance breast cancer risk stratification and screening strategies, particularly for women identified as high risk.
